S&P 500 7,674 -1.43% Nasdaq 26,180 -2.05% Dow Jones 53,277 -0.85% FTSE 100 10,817 +0.62% DAX 26,137 -1.15% Nikkei 225 65,673 -2.65% Hang Seng 25,492 +0.15% WTI Crude 85.61 -0.26% Gold 4,694 +4.56% US 10-Year Treasury Yield 4.738 +0.30% S&P 500 7,674 -1.43% Nasdaq 26,180 -2.05% Dow Jones 53,277 -0.85% FTSE 100 10,817 +0.62% DAX 26,137 -1.15% Nikkei 225 65,673 -2.65% Hang Seng 25,492 +0.15% WTI Crude 85.61 -0.26% Gold 4,694 +4.56% US 10-Year Treasury Yield 4.738 +0.30%

LATEST

Ray Dalio says investors should own ‘a bit of Bitcoin’ as U.S. debt risks rise●Bessent's $4 billion bond buyback wanted lower yields. It got a bitcoin surge instead.●Singapore inflation hits highest in nearly two years, but undershoots expectations●Sonova unveils new AI-powered hearing-aid platform to support growth targets●Alibaba shares plunge 11% after $10.2 billion share placement to fund AI expansion●Why Vishal Mega Mart share price is rising today? Stock hits the upper circuit●New Fed chair faces critical test at Jackson Hole as inflation fears mount●Walmart is selling a 2-pack of solar lights that are easy to install for only $23●Ray Dalio says investors should own ‘a bit of Bitcoin’ as U.S. debt risks rise●Bessent's $4 billion bond buyback wanted lower yields. It got a bitcoin surge instead.●Singapore inflation hits highest in nearly two years, but undershoots expectations●Sonova unveils new AI-powered hearing-aid platform to support growth targets●Alibaba shares plunge 11% after $10.2 billion share placement to fund AI expansion●Why Vishal Mega Mart share price is rising today? Stock hits the upper circuit●New Fed chair faces critical test at Jackson Hole as inflation fears mount●Walmart is selling a 2-pack of solar lights that are easy to install for only $23●

Asia

Symbiotec Pharmalab IPO opens today: GMP signals 41% upside — Should you subscribe?

Markets-Economic Times · 2h ago · 🇮🇳 India

Symbiotec Pharmalab IPO opens today: GMP signals 41% upside — Should you subscribe?

Symbiotec Pharmalab’s Rs 1,757 crore IPO opens August 24, with a Rs 938–988 price band and 41% grey-market premium. The issue combines fresh shares and an OFS, while proceeds will partly repay debt. Its specialised API manufacturing, regulatory approvals and biotechnology capabilities offer investors exposure to India’s pharmaceutical manufacturing growth.

Read the full story at Markets-Economic Times →

More Asia

Sonova unveils new AI-powered hearing-aid platform to support growth targets

Latest News · 38m ago

Alibaba shares plunge 11% after $10.2 billion share placement to fund AI expansion

mint - markets · 38m ago

Why Vishal Mega Mart share price is rising today? Stock hits the upper circuit

mint - markets · 45m ago

JGB yields edge higher amid fiscal, inflation worries

Markets-Economic Times · 47m ago